Conference Reports for NATAP

EASL - European Association for the Study of the Liver May 7-10, 2025 Amsterdam the Netherlands Back

Seladelpar Treatment of Patients With Primary Biliary Cholangitis Improves the GLOBE Score and Predicts Improved Transplant-Free Survival       EASL 2025 May 7-10 Amsterdambr   Bettina E Hansen1-3, Susheela Carroll4, Yan Zhou4, C Fiorella Murillo Perez4, Gideon M Hirschfield1 1Division of Gastroenterology and Hepatology, Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada; 2Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands; 3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; 4Gilead Sciences, Inc., Foster City, CA, USA